Telemedicine: Key Revenue Generation Source for Companies amidst COVID-19 Outbreak

Though lockdown regulations have been relaxed in most countries, individuals are still reluctant to visit doctors in person, owing to the fear of acquiring coronavirus (COVID-19). Hence, companies in the warts therapeutics market are tapping opportunities in telemedicine, since individuals prefer remote healthcare services amidst the COVID-19 era. As such, the demand for telehealth technology is anticipated to rise dramatically in the upcoming months and years. Telemedicine apps are helping to expedite the process of quality medical care in the sphere of warts therapeutics.

The critical need for social distancing between clinicians and patients has catalyzed the demand for telemedicine services in the domain of warts therapeutics. Due to high prevalence of active COVID-19 cases in the U.S., telemedicine services are expected to register a staggering market growth during the pandemic. This is expected to drive the warts therapeutics market during the forecast period.

Warts Therapeutics Market infographic

To know the scope of our report Get a Sample on Warts Therapeutics Market?

Microwave Technology Helps to Stimulate Body’s Immune System for Clearing HPV

The microwave technology is an innovative treatment option, which is transforming the market for warts therapeutics. For instance, Scotland-based medical equipment supplier Emblation Ltd., has gained proficiency in microwave technology and named it Swift, which helps to stimulate the body’s own immune system to clear the HPV (Human Papillomavirus). Thus, podiatrists and dermatologists in the warts therapeutics market are benefitting from the introduction of microwave technology devices that are similar to the functionality of mobile phones.

Warts patients in the U.K. have been long-standing sufferers of the HPV. Moreover, limited options for treatment have influenced med-tech companies to gain efficacy in the microwave technology. Since the Scottish Government banned the use of liquid nitrogen in clinics, med-tech companies have gained the opportunity to innovate in the microwave technology. Success stories of patients are fueling the demand for non-invasive microwave technology devices.

Salicylic Acid Helps Improve Clinical Outcomes Due to Cost Efficiency Attributes

There is a growing demand for wart treatment that offers no scarring post-treatment and provides lifetime of immunity against the HPV. Hence, companies in the warts therapeutics market are increasing their focus in cryotherapy, tissue keratolysis, and immunotherapy to increase patient outcomes. As such, tissue keratolysis involves the use of salicylic acid and is popular in over-the-counter (OTC) options for warts therapeutics. This is evident since salicylic acid, being a chemical destruction treatment option, is expected to register exponential revenue growth in the warts therapeutics market during the assessment period.

Warts Therapeutics Market Segmentation

Get a glimpse of the in-depth analysis through our Report Brochure

Evidence-based data shows that high efficacy of salicylic acid is grabbing the attention of both clinicians and patients. Salicylic acid’s cost efficiency and less painful attributes are being highly preferred by patients. On the other hand, topical retinoids are also emerging as anti-inflammatory agents that inhibit cell proliferation.

Topical Treatments Highly Preferred by Patients Seeking to Inhibit Cellular Proliferation

Clinical evidence of topical zinc oxide ointment holds promising potentials in warts therapeutics. As such, zinc is associated with immunotherapy, implying that the element regulates the body’s immune system to manage common warts. This explains why the revenue of immunomodulation treatment is projected for aggressive growth in the warts therapeutics market. As such, the global warts therapeutics market is estimated to reach ~US$ 2.4 Bn by the end of 2030.

Ready availability, low cost attributes, and low chance of complications associated with topical zinc oxide ointments are generating incremental opportunities for pharmaceutical companies. Clinicians are recommending zinc oxide ointments for the management of cutaneous viral warts. Similarly, Topical 5-fluorouracil (5-FU) is also emerging as an effective solution for warts, since 5-FU inhibits cellular proliferation. Hence, healthcare professionals are recommending 5-FU application under tape occlusion to derive better results in patients.

Telemedicine Apps Expedite Process of Quality Medical Care for Genital Warts Patients

The trend of telemedicine is bringing about a significant change in the warts therapeutics market. For instance, in December 2019, GenieMD— a California-based virtual care delivery company, has introduced its telemedicine app called iVisit that helps to connect genital warts patients with the best physicians through a virtual visit. Such innovations are bolstering growth for the warts therapeutics market. Thus, telemedicine is helping to expedite the process for acquiring quality medical care, which is currently the need of the hour for patients suffering from genital warts.

Companies in the market of warts therapeutics are increasing their R&D muscle in developing improved formulations of vaccines for patients who have not been previously vaccinated against HPV. On the other hand, manufacturers are increasing their production capabilities to develop prescription creams and gels that help to effectively treat genital warts.

Cryotherapy-Salicylic Acid Combination Therapy Helps Reduce Adverse Events of Scarring

Cryotherapy serves as the gold standard for the treatment of warts. As such, cryotherapy, a part of physical destruction treatment, is expected to lead the warts therapeutics market in terms of treatment types. However, possible risks of scarring and chances of infection due to cryotherapy pose a major concern for warts patients. This explains why the warts therapeutics market is slated to register a modest CAGR of ~3% during the forecast period. Hence, pharmaceutical companies are suggesting combination therapy involving salicylic acid to reduce incidence of adverse events in patients.

On the other hand, cantharidin is acquiring popularity as an ancient Chinese medicine that aids in warts therapeutics. However, cantharidin is not FDA (Food and Drug Association)-approved, which is why patients are ordering the medicine from distributors where it is commonly acceptable to use cantharidin.

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The telehealth sector is projected to experience exponential growth amidst the COVID-19 pandemic, as individuals wants to know about remote medical care services for warts management. With continued growth of telemedicine, companies in the warts therapeutics market are increasing the availability of topical ointments and bleomycin, owing to their antibacterial and antitumor properties.

The topical zinc oxide ointment improves patient outcomes. However, zinc might have different penetration profiles and deliver variable amounts of elemental zinc in different patients. Hence, companies should educate patients to seek consultation from clinicians about combination therapy of zinc oxide ointment with salicylic acid to prevent any adverse events in patients.

Warts Therapeutics Market: Overview

  • According to Transparency Market Research’s latest report on the global warts therapeutics market for the historical period 2018–2019 and forecast period 2020–2030, the global warts therapeutics market is driven by an increase in prevalence of warts & HPV infections
  • According to the report, the global warts therapeutics market was valued at US$ 1.7 Bn in 2019. It is anticipated to expand at a CAGR of ~3% from 2020 to 2030.

Increase in Prevalence of Warts & HPV Infections: Key Drivers of Warts Therapeutics Market

  • Wart is a dermatological infectious disease caused by a virus that belongs to the Human Papilloma Virus (HPV) family. HPV viruses cause excessive and rapid growth of keratin, which is a hard protein on the top layer of the skin.
  • For instance, according to the Anal Cancer Foundation, each year an estimated 14 million people are infected with HPV in the U.S. As per the Centers for Disease Control and Prevention, in the U.S., approximately 340,000 to 360,000 women and men are affected by genital warts caused by HPV every year. So, increase in prevalence of warts & HPV infections drive the warts therapeutics market.

Low Diagnostic Rate Due to Lack of Awareness: Key Restraints of Warts Therapeutics Market

  • Lack of awareness regarding diagnosis leads to fewer reported cases and subsequently, leads to less significance for treatment options, which in turn hampers the global warts therapeutics market
  • Prevalence of warts is higher among the population; however, the diagnosis rate is low in patients, this restraints the market of warts therapeutics. For instance, according to the Health Protection Report, in England, in 2018, the rate of genital warts diagnosis among girls aged 15 to 17 years attending sexual health services decreased 92% as compared to that in 2014.

Promising Pipeline: Key Trends of Warts Therapeutics

  • Prevalence of warts is increasing across the globe. Thus, key industry players engage in strategic development, focusing on research and development, in order to develop new products for warts treatment are some trend observed during the study of warts therapeutics market.
  • For instance, Verrica Pharmaceuticals specializes in the development and commercialization of dermatological treatments. Currently, the company's VP-102 is in clinical trial phase for common and external genital warts indication.
  • Novan, Inc. is a biotechnology company that engages in the development of SB206 as a topical antiviral gel for the treatment of external genital warts. SB206 is in clinical trial phase 2.

Warts Therapeutics Market: Competition Landscape

  • This report profiles major players in the global warts therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global warts therapeutics market is highly fragmented, owing to the presence of numerous international as well as regional players
  • Leading players operating in the global warts therapeutics market include 
    • GlaxoSmithKline plc
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd
    • Phio Pharmaceuticals Corp.
    • Verrica Pharmaceuticals
    • Bausch Health Companies, Inc.
    • Mylan N.V.
    • Prestige Consumer Healthcare Inc.
    • Scholl’s Wellness Co
    • Taro Pharmaceutical Industries Ltd
    • Cipla Ltd.
    • Novan Inc
    • Merck & Co., Inc. 
    • AIM ImmunoTech, Inc.

Warts Therapeutics Market: Key Developments

  • Key players in the global warts therapeutics market are engaged in regulatory approvals, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the global warts therapeutics market. A few expansion strategies adopted by players operating in the global warts therapeutics market are:
    • On July 16, 2018, Verrica Pharmaceuticals entered into a supply agreement with Funing County Development Brucea Javanica Professional Cooperatives. Under the terms of the agreement, Brucea Javanica Professional Cooperatives is projected to supply naturally sourced cantharidin (a drugs for warts treatment) to Verrica Pharmaceuticals for a specified fixed price.
  • The report on the global warts therapeutics market discussed individual strategies, followed by company profiles of manufacturers of drugs. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global warts therapeutics market.

Warts Therapeutics Market – Segmentation

Warts Type

  • Common Warts
  • Genital Warts
  • Flat Warts
  • Others

Treatment Type

Physical Destruction

  • Freezing
  • Liquid Nitrogen
  • Nitrous Oxide
  • Dimethyl Ether and Propane
  • Surgical Removal
  • Laser Treatment

Chemical Destruction

  • Bleomycin
  • Cantharidin
  • Salicylic Acid
  • Others

Immunomodulation

  • Interferons
  • Zinc
  • Retinoid

Distribution Channel

  • Hospitals
  • Clinics
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

Warts therapeutics market to reach valuation of ~US$ 2.4 Bn by 2030

Warts therapeutics market is anticipated to expand at a CAGR of ~3% from 2020 to 2030

Warts therapeutics market is driven by an increase in prevalence of warts & HPV infections

North America accounted for major share of the global warts therapeutics market

Key players in the global warts therapeutics market include GlaxoSmithKline plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd, Phio Pharmaceuticals Corp., Verrica Pharmaceuticals

Chapter 1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Warts Therapeutics Market 

Chapter 4. Market Overview

    4.1. Introduction

        4.1.1. Product Overview

    4.2. Market Dynamics 

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunity

Chapter 5. Key Insights

    5.1. Pipeline Analysis – Warts Therapeutics Market

    5.2. Global Warts Therapeutics Market – COVID-19 Impact Analysis 

    5.3. Global Warts Therapeutics Market ­– Regulatory Scenario

Chapter 6. Global Warts Therapeutics Market Analysis and Forecast, by Warts Type 

    6.1. Key Findings / Developments

    6.2. Introduction & Definition

    6.3. Global Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030

        6.3.1. Common Warts

        6.3.2. Genital Warts

        6.3.3. Flat Warts

        6.3.4. Others 

    6.4. Global Warts Therapeutics Market Attractiveness, by Warts Type

Chapter 7. Global Warts Therapeutics Market Analysis and Forecast, by Treatment Type

    7.1. Key Findings / Developments

    7.2. Introduction & Definition

    7.3. Global Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030

        7.3.1. Physical Destruction

            7.3.1.1. Freezing (Cryotherapy)

                7.3.1.1.1. Liquid Nitrogen

                7.3.1.1.2. Nitrous Oxide

                7.3.1.1.3. Dimethyl Ether and Propane

            7.3.1.2. Surgical Removal

            7.3.1.3. Laser Treatment

        7.3.2. Chemical Destruction

            7.3.2.1. Bleomycin

            7.3.2.2. Cantharidin

            7.3.2.3. Salicylic acid

            7.3.2.4. Others

        7.3.3. Immunomodulation

            7.3.3.1. Interferons

            7.3.3.2. Zinc

            7.3.3.3. Retinoid

    7.4. Global Warts Therapeutics Market Attractiveness, by Treatment Type

Chapter 8. Global Warts Therapeutics Market Analysis and Forecast, by End-user

    8.1. Key Findings / Developments

    8.2. Introduction & Definition

    8.3. Global Warts Therapeutics Market Value Forecast, by End-user, 2018–2030

        8.3.1. Hospitals

        8.3.2. Clinic

        8.3.3. Others

    8.4. Global Warts Therapeutics Market Attractiveness, by End-user

Chapter 9. Global Warts Therapeutics Market Analysis and Forecast, by Geography/Region 

    9.1. Geographical Representation

    9.2. Global Warts Therapeutics Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Warts Therapeutics Market Attractiveness, by Region

Chapter 10. North America Warts Therapeutics Market Analysis and Forecast 

    10.1. North America Warts Therapeutics Market Value Forecast, by Country , 2018–2030

        10.1.1. U.S.

        10.1.2. Canada

    10.2. North America Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030

    10.3. North America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030

    10.4. North America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030

    10.5. North America Warts Therapeutics Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Warts

        10.5.3. By Treatment Type

        10.5.4. By End-user

Chapter 11. Europe Warts Therapeutics Market Analysis and Forecast 

    11.1. Europe Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030

        11.1.1. Germany

        11.1.2. France

        11.1.3. U.K.

        11.1.4. Spain

        11.1.5. Italy

        11.1.6. Rest of Europe

    11.2. Europe Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030

    11.3. Europe Warts Therapeutics Market Value Forecast, by Treatment Type, 2018–2030

    11.4. Europe Warts Therapeutics Market Value Forecast, by End-user, 2018-2030

    11.5. Europe Warts Therapeutics Market Attractiveness Analysis

        11.5.1. By Country/Sub-region

        11.5.2. By Warts Type

        11.5.3. By Treatment Type

        11.5.4. By End-user

Chapter 12. Asia Pacific Warts Therapeutics Market Analysis and Forecast 

    12.1. Asia Pacific Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030

        12.1.1. Japan

        12.1.2. China

        12.1.3. India

        12.1.4. Australia & New Zealand

        12.1.5. Rest of APAC

    12.2. Asia Pacific Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030

    12.3. Asia Pacific Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030

    12.4. Asia Pacific Warts Therapeutics Market Value Forecast, by End-user, 2018-2030

    12.5. Asia Pacific Warts Therapeutics Market Attractiveness Analysis

        12.5.1. By Country/Sub-region

        12.5.2. By Warts Type

        12.5.3. By Treatment Center

        12.5.4. By End-user

Chapter 13. Latin America Warts Therapeutics Market Analysis and Forecast 

    13.1. Latin America Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030

        13.1.1. Brazil

        13.1.2. Mexico

        13.1.3. Rest of Latin America

    13.2. Latin America Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030

    13.3. Latin America Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030

    13.4. Latin America Warts Therapeutics Market Value Forecast, by End-user, 2018-2030

    13.5. Latin America Warts Therapeutics Market Attractiveness Analysis

        13.5.1. By Country/Sub-region

        13.5.2. By Warts Type

        13.5.3. By Treatment Center

        13.5.4. By End-user

Chapter 14. Middle East & Africa Warts Therapeutics Market Analysis and Forecast 

    14.1. Middle East & Africa Warts Therapeutics Market Value Forecast, by Country/Sub-region, 2018–2030

        14.1.1. GCC Countries

        14.1.2. South Africa

        14.1.3. Rest of Middle East & Africa

    14.2. Middle East & Africa Warts Therapeutics Market Value Forecast, by Warts Type, 2018–2030

    14.3. Middle East & Africa Warts Therapeutics Market Value Forecast, by Treatment Type, 2018-2030

    14.4. Middle East & Africa Warts Therapeutics Market Value Forecast, by End-user, 2018-2030

    14.5. Middle East & Africa Warts Therapeutics Market Attractiveness Analysis

        14.5.1. By Country/Sub-region

        14.5.2. By Warts Type

        14.5.3. By Treatment Center

        14.5.4. By End-user

Chapter 15. Competition Landscape

    15.1. Competition Matrix

        15.1.1. Prestige Consumer Healthcare, Inc.

        15.1.2. Bausch Health Companies, Inc.

    15.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        15.2.1. Prestige Consumer Healthcare, Inc.

            15.2.1.1. Company Details

            15.2.1.2. Company Description

            15.2.1.3. Business Overview

            15.2.1.4. SWOT Analysis

            15.2.1.5. Financial Analysis

            15.2.1.6. Strategic Overview

        15.2.2. Bausch Health Companies, Inc.

            15.2.2.1. Company Details

            15.2.2.2. Company Description

            15.2.2.3. Business Overview

            15.2.2.4. SWOT Analysis

            15.2.2.5. Strategic Overview

        15.2.3. Phio Pharmaceuticals Corp.

            15.2.3.1. Company Details

            15.2.3.2. Company Description

            15.2.3.3. Business Overview

            15.2.3.4. SWOT Analysis

            15.2.3.5. Strategic Overview

        15.2.4. Verrica Pharmaceuticals

            15.2.4.1. Company Details

            15.2.4.2. Company Description

            15.2.4.3. Business Overview

            15.2.4.4. SWOT Analysis

            15.2.4.5. Strategic Overview

        15.2.5. Teva Pharmaceuticals Industries Ltd.

            15.2.5.1. Company Details

            15.2.5.2. Company Description

            15.2.5.3. Business Overview

            15.2.5.4. SWOT Analysis

            15.2.5.5. Financial Analysis

            15.2.5.6. Strategic Overview

        15.2.6. Mylan N.V.

            15.2.6.1. Company Details

            15.2.6.2. Company Description

            15.2.6.3. Business Overview

            15.2.6.4. SWOT Analysis

            15.2.6.5. Financial Analysis

            15.2.6.6. Strategic Overview

        15.2.7. Scholl’s Wellness Co.

            15.2.7.1. Company Details

            15.2.7.2. Company Description

            15.2.7.3. Business Overview

            15.2.7.4. SWOT Analysis

            15.2.7.5. Financial Analysis

            15.2.7.6. Strategic Overview

        15.2.8. Taro Pharmaceuticals Industries Ltd.

            15.2.8.1. Company Details

            15.2.8.2. Company Description

            15.2.8.3. Business Overview

            15.2.8.4. SWOT Analysis

            15.2.8.5. Financial Analysis

            15.2.8.6. Strategic Overview

        15.2.9. Cipla Ltd.

            15.2.9.1. Company Details

            15.2.9.2. Company Description

            15.2.9.3. Business Overview

            15.2.9.4. SWOT Analysis

            15.2.9.5. Strategic Overview

        15.2.10. GlaxoSmithKline plc

            15.2.10.1. Company Details

            15.2.10.2. Company Description

            15.2.10.3. Business Overview

            15.2.10.4. SWOT Analysis

            15.2.10.5. Strategic Overview

        15.2.11. Novan, Inc.

            15.2.11.1. Company Details

            15.2.11.2. Company Description

            15.2.11.3. Business Overview

            15.2.11.4. SWOT Analysis

            15.2.11.5. Strategic Overview

        15.2.12. AIM ImmunoTech, Inc.

            15.2.12.1. Company Details

            15.2.12.2. Company Description

            15.2.12.3. Business Overview

            15.2.12.4. SWOT Analysis

            15.2.12.5. Strategic Overview

        15.2.13. Merck & Co., Inc.

            15.2.13.1. Company Details

            15.2.13.2. Company Description

            15.2.13.3. Business Overview

            15.2.13.4. SWOT Analysis

            15.2.13.5. Strategic Overview

List of Tables

Table 01: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030

Table 02: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 03: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030

Table 04: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing Cryotherapy, 2018–2030

Table 05: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030

Table 06: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030

Table 07: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 08: Global Warts Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 10: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030

Table 11: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 12: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030

Table 13: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030

Table 14: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030

Table 15: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030

Table 16: North America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 17: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030

Table 19: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 20: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030

Table 21: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030

Table 22: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030

Table 23: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030

Table 24: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 25: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030

Table 27: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 28: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030

Table 29: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030

Table 30: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030

Table 31: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030

Table 32: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 33: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 34: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030

Table 35: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 36: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030

Table 37: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030

Table 38: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030

Table 39: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030

Table 40: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 41: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 42: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Wart Type, 2018–2030

Table 43: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Treatment Type, 2018–2030

Table 44: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Physical Destruction, 2018–2030

Table 45: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Freezing (Cryotherapy), 2018–2030

Table 46: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Chemical Destruction, 2018–2030

Table 47: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by Immunomodulation, 2018–2030

Table 48: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figure

Figure 01: Global Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Warts Therapeutics Market Value Share, by Wart Type, 2019

Figure 03: Global Warts Therapeutics Market Value Share, by Treatment Type, 2019

Figure 04: Global Warts Therapeutics Market Value Share, by End-user, 2019

Figure 05: Global Warts Therapeutics Market Value Share, by Region, 2019

Figure 06: Global Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030

Figure 07: Global Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030

Figure 08: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Common Warts, 2018–2030

Figure 09: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Genital Warts, 2018–2030

Figure 10: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Flat Warts, 2018–2030

Figure 11: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030

Figure 12: Global Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 13: Global Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 14: Global Warts Therapeutics Market Value Share Analysis, by Physical Destruction, 2019 and 2030

Figure 15: Global Warts Therapeutics Market Attractiveness Analysis, by Physical Destruction, 2020–2030

Figure 16: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Physical Destruction, 2018–2030

Figure 17: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Chemical Destruction, 2018–2030

Figure 18: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Immunomodulation, 2018–2030

Figure 19: Global Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 20: Global Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 21: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2018–2030

Figure 22: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Clinics, 2018–2030

Figure 23: Global Warts Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Others, 2018–2030

Figure 24: Global Warts Therapeutics Market Value Share Analysis, by Region, 2019 and 2030

Figure 25: Global Warts Therapeutics Market Attractiveness Analysis, by Region, 2020–2030

Figure 26: North America Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030

Figure 27: North America Warts Therapeutics Market Value Share Analysis, by Country, 2019 and 2030

Figure 28: North America Warts Therapeutics Market Attractiveness Analysis, by Country, 2020–2030

Figure 29: North America Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030

Figure 30: North America Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030

Figure 31: North America Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 32: North America Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 33: North America Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 34: North America Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 35: Europe Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030

Figure 36: Europe Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 37: Europe Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 38: Europe Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030

Figure 39: Europe Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030

Figure 40: Europe Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 41: Europe Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 42: Europe Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 43: Europe Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 44: Asia Pacific Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030

Figure 45: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 46: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 47: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030

Figure 48: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030

Figure 49: Asia Pacific Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 50: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 51: Asia Pacific Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 52: Asia Pacific Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 53: Latin America Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030

Figure 54: Latin America Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 55: Latin America Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 56: Latin America Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030

Figure 57: Latin America Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030

Figure 58: Latin America Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 59: Latin America Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 60: Latin America Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 61: Latin America Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030

Figure 62: Middle East & Africa Warts Therapeutics Market Value (US$ Mn) Forecast, 2018–2030

Figure 63: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 64: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 65: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Wart Type, 2019 and 2030

Figure 66: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Wart Type, 2020–2030

Figure 67: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by Treatment Type, 2019 and 2030

Figure 68: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by Treatment Type, 2020–2030

Figure 69: Middle East & Africa Warts Therapeutics Market Value Share Analysis, by End-user, 2019 and 2030

Figure 70: Middle East & Africa Warts Therapeutics Market Attractiveness Analysis, by End-user, 2020–2030

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Warts Therapeutics Market